20.70USD-5.99%Mkt Cap: 1.19B $P/E: —1d ago
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconst…
Indicators:|
Key Statistics
Company
Market Cap1.19B $
Enterprise Value2.57B $
Revenue (TTM)2.28B $
Gross Profit1.35B $
Net Income (TTM)-1.18B $
Revenue/Share39.83 USD
Last Price20.70 USD
Fiscal Year EndDec 2025
MR QuarterApr 2026
Employees7.8K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)5.08
PEG3.45
EV/EBITDA6.91
EV/Revenue1.13
P/S0.52
P/B0.81
EPS (TTM)-19.89
EPS (Forward)4.08
52W Range
19.149% of range36.82
52W High36.82 USD
52W Low19.14 USD
Profitability
Gross Margin59.84%
Oper. Margin3.64%
EBITDA Margin16.34%
Profit Margin-52.69%
ROE-79.51%
ROA-30.89%
Growth
Revenue Growth5.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF217.29M $
CapEx (TTM)197.38M $
FCF Margin9.08%
FCF Yield17.36%
Net Debt1.38B $
Net Debt/EBITDA3.70
Balance Sheet
Debt/Equity0.93
Current Ratio2.04
Quick Ratio0.78
Book Value/Sh25.66 USD
Cash/Share0.5760 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split581:1000
Split DateApr 5, 2022
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)42.30 USD
Upside (mean)+104.3%
Target Range33.00 USD – 55.00 USD
$33.00+104.3% to mean$55.00
# Analysts10
Ownership
Shares Out.57.56M
Float56.59M
Insiders1.62%
Institutions119.74%
Short Interest
Short Ratio8.4d
Short % Float18.74%
Short % Out.15.72%
Shares Short9.05M
Short (prev mo.)8.40M
Technical
SMA 5023.54 (-12.1%)
SMA 20026.08 (-20.6%)
Beta1.49
S&P 52W Chg20.05%
Avg Vol (30d)853.97K
Avg Vol (10d)1.21M
Technical Indicators
RSI (14)41.5
MACD-0.5592
MACD Signal-0.6116
MACD Hist.+0.0524
BB Upper23.90 USD
BB Middle21.95 USD
BB Lower20.01 USD
BB Width17.73%
ATR (14)1.303 USD
Vol Ratio (20d)2.64x